Use of specific ion channel activating and inhibiting drugs in neuroendocrine tissue.
D000818:Animals; D005711:Gallopamil / Q000633:toxicity; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism; D007473:Ion Channels / Q000187:drug effects* / Q000502:physiology; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D011966:Receptors, LHRH; D012964:Sodium / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013779:Tetrodotoxin / Q000633:toxicity
D007473:Ion Channels; D011956:Receptors, Cell Surface; D011966:Receptors, LHRH; D007987:Gonadotropin-Releasing Hormone; D005711:Gallopamil; D013779:Tetrodotoxin; D012964:Sodium